BIO-Europe® 2016: Immunotherapies: Partnership models driving cures

November 17, 2016

While we have seen new immunotherapies enter the market and there are many exciting products in development; we have also seen recent setbacks. The field is risky and partnerships among biotechs, pharmas, and other stakeholders are critical in bringing the next generation of treatments to fruition. How can companies work together to minimize the risk, maximize the potential, and ultimately help patients?

 

 


Want to elevate your brand and connect with potential partners? The Cell & Gene Exchange brings together leaders from patient advocacy groups, industry, academia and government to network, exchange ideas and explore partnership opportunities. Learn more here.

 

Previous Video
BIO-Europe® 2016: The new frontier: Aging and health
BIO-Europe® 2016: The new frontier: Aging and health

An increasing older population is characteristic of many countries in Europe and around the world. The stra...

Next Flipbook
Partnering in the Pharma World: BIO-Europe® and industry trends 2012-2015
Partnering in the Pharma World: BIO-Europe® and industry trends 2012-2015